Human apul'inic/apyrimidinic endonuclease l/redox effector factor-1 (APEl/Ref·l) is a perfect paradigm of the functional complexity of a biological macromolecule. First, it plays a crucial role, by both redox-dependent and -independent mechanisms, as a transcriptional coactivator for different trnnscription factors, either ubiquitous (i.e., AP-1, Egr-1, NF-KB, p53, HIF) or tissue-specific (i.e., PEBP-2, Pax-Sand -8, TTF-1), in controlling different cellular processes such as apoptosis, proliferation, and differentiation. Second, it acts, as an apurinidapyrimidinic endonuclease, during the second step of the DNA base excision repair pathway, which is responsible for the repair of cellular alkylation and oxidative DNA damages. Thil'd, it controls the intracellular reactive oxygen species production by negatively regulating the activity of the Ras-related GTPase Rael. Despite these known functions of APEl/Ref-1, information is still scanty about the molecular mechanisms responsible for the coordinated control of its several activities. Some evidence suggests that the expression and subcellular localization of APEl/Ref-1 are finely tuned. APEl/Ref-1 is a ubiquitous protein, but its expression pattern differs according to the different cell types. APEl/Ref-1 subcellular localization is mainly nuclear, but cytop1asmic staining has also been reported, the latter being associated with mitochondria and/or presence within the endoplasmic reticulum. It is not by chance that both expression and sub cellular localization a1·e altered in several metabolic and proliferative disorde1·s, such as in tumors and aging. Moreover, a fundamental role played by different posttranslational modifications in modulating APEl/Ref·l functional activity is becoming eYident. In the present review, we tded to put togethe1· a growing body of information concerning APEl/Ref-l's different functions, shedding new light on present and future directions to understand fully this unique molecule. Antioxid. Redox Signal. 7,[367][368][369][370][371][372][373][374][375][376][377][378][379][380][381][382][383][384] 
INTRODUCTION

General considerations onAPEl/Ref-1 biological and molecular functions
A PEIIREF-1 is a perfect example of the functional complexity of a biological macromolecule. Its acronym reflects its at least dual nature: human apurinic/apyrimidinic (AP) endonuclease, or APEl (also HAP! or APEX), is a major constituent of the base excision repair (BER) pathway of DNA lesions. Ref-1, the acronym for redox effector factor-1, refers to its redox abilities on different redox-regulated transcription factors (TFs). Interestingly, these two activities are split into two functionally independent domains of the protein itself: the N-terminus is principally devoted to the redox activity, whereas the C-terminus exerts enzymatic activity on the abasic sites of DNA (135) . Different from the Nterminus, which is completely u11conserved, the C-terminus is highly conserved from plant to man.
Both of these two activities seem to be fundamental in the works (14, 96, 126) . APEl/Ref-1 expression is always inversely correlated with the onset of apoptosis, suggesting a role as an antiapoptotic molecule.
DNA-repair activity of APEJ/Ref-1
APEl/Ref-1 is an essential protein (136) that contributes, through its participation in the BER pathways, to the regeneration of DNA damaged by products of cell metabolism and by environmental hazards. The two best characterized functions of APEl/Ref-1 in these pathways are production of a DNA primer for repair synthesis and coordination of the repair activities ofotherBERproteins (21, 28, 47, 63, 104, 129) .
BER repairs DNA damage with a set of enzyme activities that sequentially remove the damaged base (glycosylases), in- BER repair synthesis requires a DNA primer with a 3' hydroxyl end. APEl/Ref-1 generates this end in three ways. It binds specifically (102) and processively (13) to abasic sites, generated spontaneously or by glycosylases, and cuts the 5' phosphodiester bond with its endonuclease activity to produce the primer. This endonuclease activity depends on the redox state of APEl/Ref-1, controlled in part by amino acid C310 (70) . APE 1/Ref· l removes with its 3 '-5' exonuclease activity a 3'-phospho-a,~-unsaturated aldehyde, formed by complex glycosylases [such as the oxidative damage-repairing glycosylases 8-oxoguanine DNA glcosy!ase (Oggl) and Nth] and by radiation. This activity may also contribute to the fidelity of repair synthesis by removing mispaired nucleotides (132) . And, although Jess efficiently than PNK, APEl/Ref-1 removes with its 3' phosphatase activity a 3' terminal phosphate, produced by glycosylases NEILl and NEIL2 and by radiation (63) . The repair function of APEl/ Ref-1 requires 10 evolutionarily conserved amino acids, D70, D90, E96, Y171, D210, N212, D219, D283, D308, and H309 (35) .
Coordination of these steps within the BER pathway (106) and with other DNA repair pathways is thought to be important for preventing the accumulation of toxic repair intermediates (105, 131) (each a type of DNA damage) and for increasing the overall efficiency of the pathways. Abasic sites produced spontaneously or by glycosylases can inhibit DNA and RNA polymerases, facilitate mutation, and promote single-strand breaks (129, 145) . Single-strand breaks produced by complex glycosylases and by APE!/Ref-1 can inhibit polymerases, promote recombination, and become double-strand breaks during replication, which in turn can lead to chromosome rearrangements and cell death (11) . Evidence from reconstituted systems and from cell extracts suggests that APE 1/Ref-1 contributes to coordination by interacting directly or indirectly with other BER enzymes and with other repair pathways. The molecular basis of the specificity and of the stimulatory mechanisms and the biological significance of these interactions remain to be determined.
TELLETAL.
The glycosylase MYH (MutY DNA glycosylase homologue) removes adenine and 2-hydroxyadenine mismatched with guanine or 7,8-dihydro-8-oxodeoxyguanine (89, 90) . APEl/Ref-1 increases MYH activity 10-fold in a reconstituted system by associating directly with MYH to promote the formation of efficient MYH·DNA complexes by decreasing the MYH·DNA substrate dissociation constant (142) . Immunoprecipitation and affinity chromatography show that this association requires MYH amino acids 295-317 containing the conserved motif SIPG:XZDV/I, where X and Z are any amino acids (89 In addition to its role in single-strand break repair, XRCCl may act as a scaffold to physically organize the BER process. XRCCl binds directly to APEl/Ref-1 in yeast two-hybrid, far western, and affinity chromatography assays (122) . This interaction requires the N-terminus of APEl/Ref-1, stimulates the rate of APEl/Ref-1 endonuclease activity fivefold, and stimulates the 3' phosphodiesterase activity. Extracts prepared from CHO cells defective in XRCCl activity show diminished APEl/Ref-1 endonuclease activity that is rescued by addition of XRCCl. Stimulation of this endonuclease activity may also decrease the lyase activity of Ogg 1 to increase the efficiency of repair (75) .
Coprecipitation and affinity chromatography show that PCNA, the sliding clamp processivity factor of DNA polymerases l'i and E, and FENl, the flap endonuclease oflong-patch BER, bind directly to APEl/Ref-1 (22 
Red ox regulation of TFs activities
Redox regulation of cellular functions occurs as a consequence of the so-called "redox-cellular status," which is the result of a balance between the activity of antioxidant enzymatic cell systems (such as GSH/GSSG, superoxide dismutase, catalase, peroxidases, glutathione peroxidases, etc.) and the amount of reactive oxygen species (ROS) such as superoxide anion (0 2 -'), hydrogen peroxide (Hp 2 ), and hydroxyl radical COH). These last molecules can be produced in several ways: as byproducts of respiration, thus being associated with cell proliferation rate; by external noxious agents, such as ionizing radiation (127); during pathological states in activated neutrophils (80) ; and as "second messengers" produced by intracellular enzymatic systems, such as NADPH oxidase regulated by the ubiquitous small GTPase Rael (20, 24, 43) . It therefore represents a useful tuning device for intracellular signal transduction, as is the case in cascades induced by cytokines, such as tumor necrosis factor-a or interleukin (IL)-~ (80) .
This redox regulation ultimately affects gene expression. Recently, a great body of experimental evidence suggested that these outcomes are achieved through modulation of TFs activity, Up to now, several TFs containing specific Cys residues have been demonstrated to be the target ofredox regulation. APE!/Ref-1 has been identified as a protein capable of nuclear redox activity, inducing the DNA-binding activity of several TFs, such as AP-1 (133), NF-KB (83), Myb (134), PEBP-2 (1), HLF (27) , NF-Y (81), Egr-1 (60), HIF-la (59), ATF/CREB family (134), p53 (41), Pax proteins (12, 1 IO, 112) . It accomplishes this through the control of the redox state of Cys residues located in the DNA-binding domains or within regulatory regions, such as the transactivation domain of the thyroid-specific transcription factor I (i.e., TTF-1) of the TFs themselves (115) . In order to properly bind specific DNA target sequences, these TFs require that critical Cys residues are in the reduced state. Therefore, by maintaining these cysteines in the reduced state, APE/Ref-1 provides a redox-dependent mechanism for regulation of target gene expression. APE/Ref-1 contains two cysteine residues located within the redox-active domain (Cys65 and Cys93), and previous studies show that Cys65 should be the redox-active site of the protein by using recombinant protein (123) . In agreement with the molecular model describing redox regulation exerted by APEl!Ref-1, Cys65 should interact with the sensitive cysteine residues within the DNA-binding domains of TFs. However, Jayaraman et al. (64) suggest that the stimulatory role played by APEI/Ref-1 on p53 activity may also occur in a redox-independe11t way. This has been recently corroborated by the work of Ordway et al. (85) (Fig. 2) . As it is blocked by cyclobeximide, the latter process requires de nova protein synthesis (94, 112) . Up-regulation of APEl/Ref-1 protein levels appears to have biological relevance. In fact, protein up-regulation is always associated with an increase in both redox and AP endonuclease activity, followed by an increase in cell resistance toward oxidative stress and DNA-damaging agents (46, 94) . Therefore, an important issue was the identification of extracellular signals able to increase APEl/Ref-1 gene expression.
As experimental data grew, so did research aimed at identifying biological mod\1lators of APEl/Ref-1 gene expression, such as hormones and cytokines. With respect to these observations, recent articles by our group (113, 116) (107) . In the case of the immune system, a physiological induction of APEl/Ref-1 gene expression has been recently demonstrated for at least two cell types. This is the case of human alveolar macrophages stimulated with granulocyte-monocyte colony-stimulating factor (31 ), which can be released by these cells during fibrotic processes in the lung, and of spleen B cells stimulated with CD40 ligand {78). In the first case, a functional role in AP-I transcriptional activity has been proposed. In the latter case, the CD40 triggering is functional to the activation of blk promoter operated by Pax5a and EBF TFs. A role for IL-2-stimulated APEl/Ref-1 up-regulation has also been demonstrated in a murine pro-B cell line (140) . Very recently, a functional role for this process has been suggested involving redox regulation oftelomerase activity (137).
Other soluble mediators that have been investigated dealing with APEl/Ref-1 expression are dopamine and glutare-371 doxin {Grx2) in cerebellar granule neurons. Daily et al. (17) demonstrated that the endogenous neurotransmitter of the nigrostriatal pathway, i.e., the proapoptotic dopamine, exerts an inhibitory effect onAPEl/Ref-1 expression that is squelched by the antioxidant Grx2, thus leading to NF-KB activation and to cell protection from apoptosis.
APEl/Ref-1 levels seem to act as an intracellular signaling device. In fact, its protein levels correlate with the propensity of the cell to undergo apoptosis or proliferation. In practice, modulation of APEl/Ref-1 protein expression has been described for almost every cell type depending on the particular cellular redox status induced by exposure to an oxidative environment (Table 1) The human APEl/REF-1 gene is located on chromosome 14q 11.2-12 and span 2.6 kb, and consists of four intrans and five exons, the first of which is non coding. Its cis-regulatory regions are composed of a proximal basal promoter of -300 bp containing a CpG island (Fig. 3A) . Within this area, several putative binding sites for redox-regulated (such as AP-1, Sp-1, andATF) or cyclic AMP-regulated (such as CREB) transcriptional factors are present. At the distal promoter level, at least three negative calcium-responsi\'e regulatory elements (nCAREs) were found: nCaRE-A, nCaRE-Bl, and nCaREB2 (62) . By binding to one of these regulatory elements (nCaRE-B2), APEl/Ref-1 is able to repress its own expression, thus providing a means to control its intracellular levels (62) . Therefore, APEl/Ref-1 can also exert transcriptional control by binding to specific DNA sequences in cooperation with hnRNP-L, a member of the heterogeneous ribonucleoproteins (73) . This has also been confirmed by findings demonstrating the ability of APEl/Ref-1 to repress the parathyroid hormone (PTII) gene expression (84) . In fact, PTH promoter is characterized by the presence of a nCaRE binding motif that is specifically recognized by APEl/Ref-1.
Despite the fact that the APEl/Ref-1 gene was cloned several years ago (50) and its promoter characterized in detail (52), very few articles have addressed the molecular mechanisms responsible for its inducible regulation. Up to 11ow, the unique ascertained contributors to APEl/Ref-1 transcrip- (40) . These last results were obtained in the case of the mouse promoter. However, as a conserved Sp-1 binding site located downstream from the +1 transcription start site is present in the human promoter (region about +76 to +85), a similar behavior could be expected. Very recently, an important role in the control of APEl/Ref-1 gene expression has also been suggested for the signal transducer and activator of transcription-3 (Stat3) TF in liver ( 48) , suggesting a new mechanism of protection against Fas-medi· ated liver injury. These findings confirm that much work remains to be done in order to elucidate, in detail, the molecular mechanisms of controlling APEi/Ref-i gene expression.
Due to the fact that recombinant APEl/Ref-1 expressed in E. coli fully retains functional redox and endonuclease activity, it was erroneously thought for several years that APEI/ Ref-1 was not subjected to PT modifications. The only functional exception to perfectly similar behavior between endogenous and recombinant APEI/Ref-1 was represented by a differential binding activity toward the nCaRE sites. In fact, recombinant APEl/Ref-1 alone was not able to bind to both nCaRE-A and nCaRE-B in the PTH gene promoter, indicat· ing a requirement for additional factors in the complex ( 16, 73) . These observations led to the identification of Ku70 (K.u86) and hnRNP-L involvement in the complex formation with nCaRE-A and nCaRE-B, respectively. Moreover, APEl/ Ref-I is an abundant protein in a eukaryotic cell. We have estimated that~ 10-3 0,000 copies of the protein are present in a thyroid cell. Therefore, it is possible that many proteins for many different functions have to be "finely tuned" in order to coordinate specific biological activities. The best choice for a biological system to "recycle" the same protein for different biological activities is by means of PT modifications. First, in silico studies soon discovered that several different phosphorylation sites were scattered throughout the molecule. These potential phosphorylation sites included consensus sequences for casein kinase I and II (CKl and CKII), for protein kinase C (PKC), and for glycogen synthase kinase 3 (GSK3) {Fig. 3B) (34, 139) . These two pioneering studies were, however, in disagreement regarding the potential phosphorylation sites determined and the functional consequences ofi11 vitro phosphorylation.
These first studies were performed in vitro by using the re- (123, 124, 135) , it could be speculated that target residues of TRX interaction may include these two cysteine residues. This TRX-mediated redox regulation of APEl/Ref-1 is required for p53 and AP-I functional activation (55, 121). Very recently, Kelley and Parsons (70) demonstrated that the repair activity is also redox-regulated with the specific involvement ofC310 residue located immediately adjacent to the crucial histidine residue at position 309 within the DNA repair active site. Interestingly, oxidation occurring at other Cys residues located in the redox domain Fig. 3C ).
Together, these recent observations have raised the possibility that subtle PT modifications provide a means for channeling the multifunctional APEl/Ref-1 to different activities and interactions and thus could act as a regulatory switch in performing different functions. (119) . Due to occurrence of oxidative phosphorylation, mitochondria produce a large amount of ROS. Mita· chondrial DNA (mtDNA), being located in the mitochondrial matrix, is extremely susceptible to oxidative damage, which represents a major mutational drive for mtDNA itself. The ex-375 istence of DNA repair devices in mitochondria is still up for debate (8 Moreover, cytoplasmic localization may be required in order to maintain newly synthesized TF in a reduced state while they are being translocated to the nucleus. In this respect, Duguid et al. (25) (40) could explain this. These data, paired with the demonstration of cell cycle-dependent hMYH glycosylase expression (9) , suggest that coordinated expression of key DNA repair genes with the cell cycle is a general phenomenon. Moreover, as APEl/Ref-1 plays an important role in contributing to p53-mediated cell-cycle arrest ( 41) by regulating p53 TF activity through both redox-dependent and -independent mechanisms (64), and it is down-regulated during apoptosis in myeloid leukemia cells (96) , then it is possible that the role of cell cycle-responsive APEl/Ref-1 expression relates to one of these other functions rather than to DNA repair.
REGULATION OF APEl/Ref-1 FUNCTIONS: AT THE SUB CELLULAR LOCALIZATION LEVEL
Finally, in many cell types, APEl/Ref-1 displays both 1rn-clear and cytoplasmic localization. These cell types include normal thyroid cells stimulated by TSH, transformed thyroid cells {113), mucosa! and parietal cells of the stomach, cerebellar Purkinje cells, adrenal cortical cells, and some cervical cells (67, 95) . Therefore, to sum up, APEl/Ref-1 subcellular localization is quite varied. Some cell types exhibit only nuclear localization, others display only cytoplasmic, and some others show both nuclear and cytoplasmic localization. Such a complex staining pattern suggests that localization is not random but, on the contrary, is governed by a strictly regulated process. The understanding of the biological relevance of subcellular compartmentalization is now at its very begiru1ing, but recent articles suggest that this field shows much promise.
APEl/Ref-1 FUNCTIONS, SUBCELLULAR MOVEMENT, AND TRAFFICKING
Generally, stimuli that promote APEl/Ref-1 expression are also able to promote its intracellular movement. The amount of evidence reporting APEl/Ref-1 subcellular relocalization upon a stimulus has grown exponentially in the last few years and is shown in Table 2 ( 42), hypoxia/reoxygenation in endothelial cells (2), cysteamine-induced duodenal ulceration (71) , and aging (15); (b) heavy metals exposure, such as macrophages exposed to asbestos (32) , and primary astrocyte cultures exposed to Pb (100) 
TELLETAL.
is able to induce translocation of APE 1/Ref-1 into the nucleus (unpublished observations), suggesting that the nuclear form of APE! could be hypophosphorylated. Therefore, it is tempting to speculate that a dephosphorylating event is required for the nuclear localization of APEl/Ref-1 in thyroid cells, as in the case of the NF-AT TF (103) .
As APEl/Ref-1 directly and physically interacts with redox-regulated TFs, this raises the possibility that nuclear relocalization could be, at least in part, due to a co-transportation mechanism by those TFs, such as NF-KB, that are specifically relocalized to the nucleus due to a stimulus and have been demonstrated to functionally interact with APEl/ Ref-1 itself. This would not represent an isolated case of such a mechanism, being corroborated by recent reports for a role in cotransport of ~-catenin by the LEF-1 TF (61).
Another interesting evidence is the case of the observed relocalization of APEI/Ref-1 into mitochondria of the B-lymphocyte Raji cell line following Hp 2 activation (36). This relocalization is not associated with cytochrome c loss or with apoptosis induction, thus indicating that the APEl/Ref-1 translocation into mitochondria upon oxidative stress might exert a protective function toward mtDNA damages produced by both exogenous and endogenous ROS. Due to the relatively high molecular weight of APEl/Ref-1, which is not fully compatible with a passive mechanism of translocation through the outer membrane of mitochondria, the presence of a specific regulatory transport mechanism could be hypothesized. Although a large majority of proteins synthesized in the cytoplasm localize into mitochondria by means of an Nterminal presequence, or mitochondrial targeting sequence (MTS), a significant fraction of mitochondrial proteins lack this recognition signal. Little is known about other mitochondrial targeting signals, but there could be targeting signals within the molecule itself. This is the situation, for instance, in the heme lyases that have, in the third qnarter of the molecule, a hydrophilic stretch of residues that represent a topogenic signal for protein sorting into the intermembrane space (23) . APEI/Ref-1 does not present a classical mitochondrial N-terminal presequence while presenting, in the same region, a typical NLS in the first 20 residues. Therefore, it could be speculated that the mitochondrial localization signal may reside in another region of the molecule instead of the N-terminus. Obviously, identification of such a signal would represent an important discovery that would elucidate some of the functional roles ofAPEl/Ref- 
ALTERED EXPRESSION/DISTRIBUTION OF APEl/Ref-1 AND HUMAN PATHOLOGY
The multifunctional properties of APEl/Ref-1 closely parallel the differential expression pattern found in a wide spectrum of cells first realized by Kakolyris et al. in 1998 (67) . In the following years, many articles observed that this heterogeneity of expression pattern is also linked to different pathological conditions ranging from metabolic to differentiative disorders. Early studies by Kakolyris et al. showed that different kinds of human tumors were characterized by alterations in subcellular distribution of APEl/Ref-1 with respect to normal tissue. This is the case, for instance, in colorectal carcinoma. In normal colorectal mucosa, the predominant staining is nuclear in the less differentiated cells of the lower part of the crypt, but is cytoplasmic in the more differentiated and superficial colonic epithelium. This distribution is completely disrupted during tumorigenesis because the nuclearrestricted pattern is lost in both adenoma and carcinoma, which display nuclear and cytoplasmic localization with a predomination of the latter, in front of a prominent nuclear localization in the normal tissue (65) . A similar pattern has been described for breast cancer. In normal tissue, the APEI/Ref-1 localization is eminently nuclear, whereas in carcinomas, nuclear, cytoplasmic, and nuclear/cytoplasmic stainings were observed. This peculiar distribution correlates well with aggressiveness and prognosis of the tumor: nuclear localization was always associated with a better prognostic feature being related to better differentiation, low angiogenesis, and negative lymph node status. In contrast, both the cytoplasmic and the nuclear/cytoplasmic stainings were associated with poor prognostic factors, such as angiogenesis together with node and p53 positivities (66, 92) . Interestingly, there seems to be no functional relationship between alterations in subcellular distribution of APEI/Ref-1 and the ability of cancerous tissue to repair abasic sites, suggesting that, at least in breast cancer, DNA repair by BER is not affected (98) . As an aside, Bobola et al. (7) demonstrated that even an increase in AP endonucleasic activity occurs in human gliomagenesis with a concomitant elevation of APEl/Ref-1 protein expression level. Similar observations have also been made by Robertson et al. (97) . In different germ cell tumors, such as seminomas, yolk sac tumors, and malignant teratomas, APEl/Ref-1 expression levels and DNA repair ability correlated and conferred a proportional level of protection from bleomycin treatment. These outcomes suggest that a consequence of the increase in AP activity accompanying tumorigenesis could be enhanced resistance to radiotherapy and chemotherapy.
A disregulation in nuclear versus cytoplasmic ratio toward a more cytoplasmic staining was also observed in thyroid carcinomas (113) and epithelial ovarian cancers (79) (42) suggests that, in the case of CA I pyramidal neurons, these discrepancies could be due to the presence of a posttranscriptional block during the translation process or to an increased degradation of the protein upon ischemia. Interestingly, it was also demonstrated that APEl/Ref-1 may undergo ubiquitination by Ubc9 enzyme ( 141 ) . A similar decrease of APE l/Ref-1 protein levels was recently observed in motor neurons in a rabbit model of spinal cord ischemia by Sakurai et al. (99) . It is noteworthy that this reduction preceded oxidative DNA damage and may constitute one of the factors responsible for the delay in neuronal death after spinal cord ischemia. It is probably not casual that cells characterized by a high rate of metabolic activities, such as neurons, are also vulnerable when DNA repair or redox controlling systems are defective. In fact, these cells are a particular target of the noxious effects of ROS at both the DNA and protein levels. Another important neurological disorder with which APEl/Ref-1 has been associated is Alzheimer's disease. Hippocampi of affected patients show an increase inAPEl/Ref-1 levels in senile plaques and plaque-like structures (109) . This evidence accounts for a wider involvement of the DNA repair mechanisms in Alzheimer's disease, as recently suggested by Davydov et al. (19) .
Recent evidence also points to a role of APEl/ (10) . In the second case, an up-regulation of APEI/Ref-1 and TRX was associated with preeclampsia and intrauterine growth restriction in complicated pregnancies, definitively suggesting that cellular redox regulation is affected in the pathophysio[ogy of this disorder (108) .
CONCLUDING REMARKS AND PERSPECTIVES
APEI/Ref-1 is a perfect paradigm of the functional complexity of a biological macromolecule. First, as a transcriptional coactivator, it impacts on a wide variety of ce!Iular functions ranging from the control of proliferation to apoptosis, cytokines, and hormone signaling where ROS are mainly produced and function as second messengers. Second, as a DNA-repair enzyme, it plays a fundamental role in the BER pathways of DNA lesions caused by oxidants and/or alkylating agents. Therefore, asAPEl/Ref-1 is a master player of the above-mentioned cellular decisions, it is not surprising that (a) it is critical to the survival of animals (136); (b) it is ubiquitously expressed in every cell type, and (c) generally, it is quite abundantly expressed. However, for a coordinated and strictly integrated functioning of APEl/Ref-1 in the proper biological context, it is necessary that its different functions must be highly regulated. It is known that APEl/Ref-1 is an inducible protein whose expression is controlled mainly at the transcriptional level by the action of APEl/Ref-1 itself, which functions as a suppressor of its own promoter activity (62) , thus constituting an autoregulatory loop. Moreover, it is coming to light that compartmentalization of the protein in different subcellular districts, such as nucleus, ER, or mitochondria, may explain the different functional specificities. This is particularly reinforced by its complex and heterogeneous staining pattern, which is typical of each cell type, and by the fact that the peculiar subcellular distribution is usually lost during cancer progression, or a cytoplasm to nucleus translocation occurs upon oxidative stimuli in different cell types. All this evidence suggests that subcellular localization and trafficking of APEl/Ref-1 should be highly regulated processes. However, they open another problem by shifting the molecular question to the mechanisms responsible for the control of a so highly regulated process. Hopefully, convinc- 
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